Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-19-032879
Date:2019-11-14
Issuer: MEDTRONIC PLC (MDT)
Original Submission Date:

Reporting Person:

COYLE MICHAEL J
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS, MN 55432

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
ORDINARY SHARES 2019-11-14 M 900 a $38.81 189,162 direct
ORDINARY SHARES 2019-11-14 S 900 d $109.52 188,262 direct
ORDINARY SHARES 2019-11-14 M 1,202 a $41.60 189,464 direct
ORDINARY SHARES 2019-11-14 S 1,202 d $109.95 188,262 direct
ORDINARY SHARES 2019-11-14 0 $0.00 250 indirect
ORDINARY SHARES 2019-11-14 0 $0.00 4,104 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 38.81 2019-11-14 deemed execution date M 900 (d) 2022-07-30 ordinary shares 900 $38.81 36,874 direct
STOCK OPTION (RIGHT TO BUY) 41.6 2019-11-14 deemed execution date M 1,202 (d) 2022-10-29 ordinary shares 1,202 $41.60 0 direct
Footnotes
IDfootnote
f1 the transactions reported on this form 4 were effected pursuant to a rule 10b5-1 trading plan.
f2 the price reported in column 4 is a weighted average price. the shares were sold in multiple transactions at prices ranging from $109.50 to $109.61, inclusive. the reporting person undertakes to provide to medtronic plc , any security holder of medtronic plc, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this form 4.
f3 this option to purchase 75,548 new medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 75,548 medtronic common stock shares for $38.81 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option.
f4 this option to purchase 2,404 new medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the merger, was received in the merger and represents the conversion of 2,404 medtronic common stock shares for $41.60 per share. this new medtronic stock option has the same terms and conditions as the original medtronic stock option.
WhaleWisdom Logo

Elevate your investments